"Cross Protection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus.
| Descriptor ID |
D056738
|
| MeSH Number(s) |
G12.450.275
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cross Protection".
Below are MeSH descriptors whose meaning is more specific than "Cross Protection".
This graph shows the total number of publications written about "Cross Protection" by people in this website by year, and whether "Cross Protection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 2 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2017 | 12 | 10 | 22 |
| 2018 | 2 | 10 | 12 |
| 2019 | 6 | 5 | 11 |
| 2020 | 2 | 2 | 4 |
| 2021 | 2 | 7 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Cross Protection" by people in Profiles.
-
Seven-month kinetics of SARS-CoV-2 antibodies and role of pre-existing antibodies to human coronaviruses. Nat Commun. 2021 08 06; 12(1):4740.
-
COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021 06 28; 12(1):3991.
-
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Science. 2021 08 27; 373(6558):991-998.
-
Cross-reactive serum and memory B-cell responses to spike protein in SARS-CoV-2 and endemic coronavirus infection. Nat Commun. 2021 05 19; 12(1):2938.
-
Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet. 2021 05 29; 397(10289):2043-2046.
-
The dream vaccine. Science. 2021 Apr 16; 372(6539):227-231.
-
Cross-immunity and trained immunity in explaining variable COVID-19 mortality-Guidance for future pandemics. J Med Virol. 2021 Jul; 93(7):4094-4096.
-
Bacille Calmette-Guérin (BCG) vaccine and potential cross-protection against SARS-CoV-2 infection - Assumptions, knowns, unknowns and need for developing an accurate scientific evidence base. Int J Infect Dis. 2021 Dec; 113 Suppl 1:S78-S81.
-
In silico comparative study of SARS-CoV-2 proteins and antigenic proteins in BCG, OPV, MMR and other vaccines: evidence of a possible putative protective effect. BMC Bioinformatics. 2021 Mar 26; 22(1):163.
-
Sharing a household with children and risk of COVID-19: a study of over 300 000 adults living in healthcare worker households in Scotland. Arch Dis Child. 2021 12; 106(12):1212-1217.